Community News

IRVINE, Calif.--(BUSINESS WIRE)-- #COVID19--While studying the effects of androgens on hair loss, Applied Biology scientists discovered an association between cellular receptors that predispose an individual to develop common hair loss (androgenetic alopecia) and COVID-19. The receptors called Androgen Receptors (AR) are expressed in lung cells and regulate a key enzyme (TMPRSS2) required for SARS-CoV-2 infectivity. Applied Biology scientists are believed to be the first to publish this […]

SANTA MONICA, Calif.--(BUSINESS WIRE)--Doctor Evidence (“DRE”) has developed new tools for automated network meta-analysis, to now be used in the hunt for the most effective treatments for COVID-19. Clinical trial data is continuously emerging that can now be aggregated in real time using DRE’s DOC Analytics™ platform. Based on the World Health Organization's International Clinical Trials Registry Platform (WHO ICTRP), as of July 12th there are some 1,798 COVID-19 […]

IRVINE, Calif.--(BUSINESS WIRE)-- 

IRVINE, Calif.--(BUSINESS WIRE)--Masimo UniView: 60™ is a digital charting solution that uses the Masimo Hospital Automation™ platform to aggregate and display pertinent patient info.

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA) today announced that to support the health and well-being of its shareholders, employees, directors, and communities due to the public health threat of the COVID-19 pandemic the Company’s upcoming 2020 Annual Meeting of Shareholders (the “Annual Meeting”) will be held in a virtual-only format. As previously announced, the Annual Meeting will be held on Thursday, July 30, 2020, at 8:30 a.m. PT, but […]

LOS ANGELES--(BUSINESS WIRE)--XS Announces Closing of Acquisition for California Lenders License

BREA, Calif.--(BUSINESS WIRE)-- #cancercosts--New Century Health announces NCQA accreditation in Utilization Management, one of its value-adding oncology and cardiology management offerings.

VALENCIA, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)--AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that the Biomedical Advanced Research and Development Authority (BARDA), a part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and […]

LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- #INDstatus--PharmaCyte Biotech has passed the Container Closure Integrity test required by the FDA for its product that will be used in its cancer clinical trial.

IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (SNM) devices for the treatment of urinary and bowel dysfunction, today reported preliminary unaudited second quarter 2020 revenue and provided an operational update. Recent Business and Financial Highlights Preliminary unaudited net revenue is expected to be $15.2 million for the second quarter 202

TUSTIN, Calif.--(BUSINESS WIRE)--At this year’s Society of Nuclear Medicine and Molecular Imaging’s (SNMMI) first-ever virtual annual meeting, Canon Medical Systems USA, Inc. is showcasing its molecular imaging portfolio, including the Cartesion Prime digital PET/CT and the Celesteion PUREViSION Edition PET/CT system. Canon Medical’s unique take on its virtual booth will feature a variety of one-of-a-kind digital experiences for customers, including: Augmented reality: […]

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced today 3rd quarter & YTD FY2020 financial results. 3QFY20 & YTD revenues up 24%. Board declares $0.06/share cash dividend.

VALENCIA, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)--AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today preliminary unaudited results for the fourth quarter and full year ended June 30, 2020, together with a company update. Preliminary Unaudited Results for Three Month Period Ended June 30, 2020 With […]

LOS ANGELES--(BUSINESS WIRE)--Kernel announced today the close of a $53M Series C round of venture financing, led by General Catalyst, with participation from Khosla Ventures, Eldridge, Manta Ray Ventures, Tiny Blue Dot and Kernel founder and CEO, Bryan Johnson. This financing represents the first outside funding of the company, following founder Bryan Johnson’s $54M investment to date. The new capital will be directed towards further technology development and customer success. General […]

LOS ANGELES--(BUSINESS WIRE)--XS Announces Third Draw-down from PharmaCann

LOS ANGELES--(BUSINESS WIRE)---- $CDXC #CellularHealth--ChromaDex Corp. (NASDAQ:CDXC) today announced the latest preclinical findings indicating Niagen® (patented nicotinamide riboside) inhibits replication of a form of Coronavirus, the virus that causes COVID-19 infection, in mouse cells. The preclinical study results were published July 8 on scientific publishing website bioRxiv.org. The research conducted jointly at the University of Iowa, Oregon Health & Science University, and the […]

PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharma will report earnings on August 5, 2020

VALENCIA, Calif.--(BUSINESS WIRE)--UltraViolet Devices, Inc. (UVDI) announced its UVDI-360 Room Sanitizer is the first 254nm UV-C disinfecting robot to be recognized by global Healthcare leader 3M as a coronavirus decontamination method that will not damage its respirators. 3M’s June Technical Bulletin “Decontamination Methods for 3M Filtering Facepiece Respirators such as N95 Respirators” now includes the UVDI-360 Room Sanitizer as safe for up to ten N95 use cycles. To be […]

MONROVIA, Calif. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, and Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, today announced that the […]

LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- #3monthstabilitystudypassesalltests--PharmaCyte Biotech successfully completed the three-month product stability testing that is required by the FDA. The product passed all FDA tests.